09.01.06
NZyme Pharmaceuticals, Inc., Pagosa Springs, CO, has filed a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease such as heart attacks and ischemic strokes, essential hypertension and deep vein thrombosis. Subtilisin NAT is a pro-fibrinolytic enzyme that is present in a vegetable cheese-like food called Natto, which is popular in Japan and has been consumed for over 1000 years.